GlassScriptPhysician profile
Irina Magidina
NPI 1487815924
$9,914.16
in general payments reported to CMS, 2019-2025
30 companies · $572 in 2025
The $572 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $342 · 2021: $4,505 · 2022: $981 · 2023: $1,734 · 2024: $919 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,110.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $6,408.66 | 2019-2024 | |
| Abbvie INC. | $852.94 | 2019-2024 | |
| Astellas Pharma US INC | $405.88 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $367.07 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $269.23 | 2023-2025 | Myfembree, Gemtesa |
| Millicent US INC | $187.00 | 2019-2025 | Femring, Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $142.11 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $135.26 | 2019-2025 | Slynd |
| Organon LLC | $111.16 | 2022-2024 | |
| Therapeuticsmd, INC. | $100.11 | 2019-2021 | |
| Bard Access Systems, INC. | $99.70 | 2019 | |
| Avion Pharmaceuticals | $96.48 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.40 | 2020-2024 | |
| Allergan, INC. | $88.21 | 2019-2020 | |
| Intuitive Surgical, INC. | $82.04 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $62.84 | 2019 | |
| Medtronic, INC. | $55.15 | 2022 | |
| Sage Therapeutics, LLC | $49.92 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $45.35 | 2025 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $37.98 | 2019 | |
| Coopersurgical, INC. | $32.53 | 2019 | |
| Evofem Biosciences, INC. | $31.37 | 2021 | |
| Aspira Women'S Health INC | $26.94 | 2024 | Ova1 |
| Hologic Sales and Service, LLC | $25.43 | 2021 | |
| Medicem INC. | $21.81 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.40 | 2025 | Qelbree |
| Amag Pharmaceuticals, INC. | $17.47 | 2020 | |
| Monaghan Medical Corporation | $16.46 | 2023 | Aerobika |
| Merck Sharp & Dohme LLC | $16.01 | 2021 | |
| Lupin INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Magidina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.